Stock listing
Cingulate Inc.
Selected listing: CING · NASDAQ · USD · US
Cingulate Inc. (NASDAQ:CING), Health Technology. Latest release Sep 17, 2026: Shane Schaffer, Cingulate Chairman & CEO to Present “SMART Launch” Approach…
- Ticker
- NASDAQ:CING
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
About Cingulate Inc.
Cingulate Inc. is a public company traded under the ticker CING in the American market. Cingulate focuses on developing innovative solutions in the healthcare sector.
Latest news from Cingulate Inc.
Shane Schaffer, Cingulate Chairman & CEO to Present “SMART Launch” Approach at Indegene Digital Summit: Rethinking Commercialization for Emerging Pharma
September 17, 2026
Cingulate Inc. Reports Second Quarter 2026 Financial Results and Provides Update on CTx-1301 CMC Progress Towards NDA Resubmission and Commercial Readiness
August 13, 2026
Cingulate Publishes Peer-Reviewed Data Demonstrating CTx-1301’s Differentiated Pharmacokinetic Profile
August 11, 2026
Cingulate Announces Publication of Phase 3 ADHD Trial Results in Journal of Child and Adolescent Psychopharmacology
July 30, 2026
Cingulate Inc. (NASDAQ: CING) Added to Russell 3000E®
July 1, 2026